Cytotoxicity against human ovarian cancer cells (A2780) with an IC50 value of 66.78 ± 5.49 μM [68] Prolyl endopeptidase inhibitory effects with an IC50 value of 1.74 ± 0.03 μM [73]. Here, PREP is linked to ovarian carcinoma.